study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MUSC-MSK09-01,2023,randomized controlled trial,SMD,0.237,0.0709,0.4031,75,85,mixed,10.1234/musc-msk09-01,musculoskeletal-journal-01,joint_health,Adults with joint health concerns,None reported,10
MUSC-MSK09-02,2014,randomized controlled trial,SMD,0.2316,0.083,0.3802,88,70,low,10.1234/musc-msk09-02,musculoskeletal-journal-02,joint_health,Adults with joint health concerns,Transient headache,8
MUSC-MSK09-03,2019,randomized controlled trial,SMD,0.2262,0.0952,0.3572,71,85,low,10.1234/musc-msk09-03,musculoskeletal-journal-03,joint_health,Adults with joint health concerns,Mild GI discomfort,13
